A large majority of OTC companies are unable to deliver on their promises, spin up investors, fail and then leave a bad taste and worthless shares in investors mouths.
ILUS has literally spelled out their plans every step of the way since they dropped the initial letter in January, 2021… and delivered along the way.
Dumb to doubt them after a year of empirical data showing continued results.